Hope on the horizon: FDA approves eplontersen for hereditary transthyretin-mediated amyloidosis

被引：0
|
作者：
Anwar, Insa Binte [1 ]
Ahmed, Iqra Furqan [1 ]
Mahmood, Fariha [1 ]
Haseeb, Abdul [2 ]
Ahmed, Khabab Abbasher Hussien Mohamed [3 ]
机构：
[1] Liaquat Natl Med Coll, Karachi, Pakistan
[2] Jinnah Sindh Med Univ, Karachi, Pakistan
[3] Univ Khartoum, Fac Med, Khartoum 11111, Sudan
来源：
ANNALS OF MEDICINE AND SURGERY | 2025年 / 87卷 / 01期
关键词：
D O I：
10.1097/MS9.0000000000002839
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：20 / 23
页数：4
相关论文
共 50 条
  • [31] Neurofilament light chain (NfL) as a potential biomarker in hereditary transthyretin-mediated (hATTR) amyloidosis
    Ticau, Simina
    Sridharan, Gautham
    Tsour, Shira
    Cantley, William
    Vaishnaw, Akshay
    Nioi, Paul
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2020, 25 : S13 - S13
  • [32] Impact of Patisiran, an RNAi Therapeutic, on Diarrhea Symptoms in Patients With Hereditary Transthyretin-Mediated Amyloidosis
    Obici, Laura
    Gonzalez-Duarte, Alejandra
    Waddington-Cruz, Marcia
    Lin, Hollis
    Merkel, Madeline
    Wang, Yue
    Ueda, Mitsuharu
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S1657 - S1657
  • [33] Indirect treatment comparison of the efficacy of patisiran and inotersen for hereditary transthyretin-mediated amyloidosis with polyneuropathy
    Gorevic, Peter
    Franklin, Jaclyn
    Chen, Jihong
    Sajeev, Gautam
    Wang, Jessie C. H.
    Lin, Hollis
    EXPERT OPINION ON PHARMACOTHERAPY, 2021, 22 (01) : 121 - 129
  • [34] Expert opinion on monitoring symptomatic hereditary transthyretin-mediated amyloidosis and assessment of disease progression
    Adams, David
    Algalarrondo, Vincent
    Polydefkis, Michael
    Sarswat, Nitasha
    Slama, Michel S.
    Nativi-Nicolau, Jose
    ORPHANET JOURNAL OF RARE DISEASES, 2021, 16 (01)
  • [35] Effect of Eplontersen on Cardiac Structure and Function in Patients With Hereditary Transthyretin Amyloidosis
    Masri, Ahmad
    Maurer, Mathew S.
    Claggett, Brian L.
    Kulac, Ian
    Cruz, Marcia Waddington
    Concei, Isabel
    Weiler, Markus
    Berk, John L.
    Gertz, Morie
    Gillmore, Julian D.
    Rush, Stephen
    Chen, Jersey
    Zhou, Wunan
    Kwoh, Jesse
    Duran, Jason M.
    Tsimikas, Sotirios
    Solomon, Scott D.
    JOURNAL OF CARDIAC FAILURE, 2024, 30 (08) : 973 - 980
  • [36] SWITCHING FROM INOTERSEN TO EPLONTERSEN IN PATIENTS WITH HEREDITARY TRANSTHYRETIN AMYLOIDOSIS POLYNEUROPATHY
    Conceicao, Isabel
    Weiler, Markus
    Kowacs, Pedro
    Dasgupta, Noel
    Khella, Sami
    Chao, Chi-Chao
    Attarian, Shahram
    Jung, Shiangtung
    Chen, Jersey
    Schneider, Eugene
    Viney, Nicholas
    Gertz, Morie
    Masri, Ahmad
    Cruz, Marcia Waddington
    Coelho, Teresa
    Berk, John
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2024, 29 : S138 - S139
  • [37] Patisiran for the Treatment of Transthyretin-mediated Amyloidosis with Cardiomyopathy
    Ioannou, Adam
    Fontana, Marianna
    Gillmore, Julian D.
    HEART INTERNATIONAL, 2023, 17 (01): : 27 - 35
  • [38] Patient experience in a rare disease: application of the IEXPAC questionnaire in hereditary transthyretin-mediated amyloidosis
    Pelaez Bejarano, Ana
    de las Aguas Robustillo Cortes, Maria
    Guzman Ramos, Maria Isabel
    EXPERT OPINION ON ORPHAN DRUGS, 2021, 9 (06): : 175 - 180
  • [39] Impact of Patisiran, an RNAi Therapeutic, on Orthostatic Intolerance in Patients with Hereditary Transthyretin-Mediated Amyloidosis
    Judge, Daniel P.
    Gonzalez-Duarte, Alejandra
    Dispenzieri, Angela
    Lin, Hollis
    Merkel, Madeline
    Wang, Yue
    Polydefkis, Michael
    JOURNAL OF CARDIAC FAILURE, 2019, 25 (08) : S78 - S78
  • [40] Neurofilament Light Chain (NfL) as a Potential Biomarker in Hereditary Transthyretin-Mediated (hATTR) Amyloidosis
    Nioi, Paul
    Ticau, Simina
    Sridharan, Gautham
    Tsour, Shira
    Cantley, William
    Chan, Amy
    Gilbert, Jason
    Erbe, David
    Fitzgerald, Kevin
    NEUROLOGY, 2020, 94 (15)
12345